LEOVAL

Antiepileptic

Levetiracetam

Composition

Each coated tablet of LEOVAL 500 mg contains:
Levetiracetam 500 mg
Excipients q.s.

Each coated tablet of LEOVAL 1000 mg contains:
Levetiracetam 1000 mg
Excipients q.s.

Presentations

LEOVAL 500 mg: package with 30 coated tablets
LEOVAL 1000 mg: package with 30 coated tablets

Indications

LEOVAL is indicated as monotherapy in the treatment of partial onset seizures, with or without secondary generalization in adults and adolescents over 16 years of age with a new diagnosis of epilepsy.

LEOVAL is indicated as concomitant therapy:
- In the treatment of partial onset seizures with or without secondary generalization in adults, adolescents and children over 4 years of age with epilepsy.
-In the treatment of myoclonic seizures in adults and adolescents over 12 years of age with Juvenile Myoclonic Epilepsy.
-In the treatment of primary generalized tonic-clonic seizures in adults and adolescents over 12 years of age with Generalized Idiopathic Epilepsy.